vs
Side-by-side financial comparison of Omnicom Group (OMC) and Stryker Corporation (SYK). Click either name above to swap in a different company.
Stryker Corporation is the larger business by last-quarter revenue ($7.2B vs $6.2B, roughly 1.1× Omnicom Group). Stryker Corporation runs the higher net margin — 11.8% vs 6.7%, a 5.1% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs -16.2%). Over the past eight quarters, Omnicom Group's revenue compounded faster (27.3% CAGR vs 16.9%).
Omnicom Group Inc. is an American global media, marketing, and corporate communications holding company, headquartered in New York City.
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
OMC vs SYK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.2B | $7.2B |
| Net Profit | $418.7M | $849.0M |
| Gross Margin | — | 64.5% |
| Operating Margin | 10.4% | 25.2% |
| Net Margin | 6.7% | 11.8% |
| Revenue YoY | -16.2% | 11.4% |
| Net Profit YoY | 38.0% | 55.5% |
| EPS (diluted) | $1.35 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.2B | — | ||
| Q4 25 | $5.5B | $7.2B | ||
| Q3 25 | $4.0B | $6.1B | ||
| Q2 25 | $4.0B | $6.0B | ||
| Q1 25 | $3.7B | $5.9B | ||
| Q4 24 | $4.3B | $6.4B | ||
| Q3 24 | $3.9B | $5.5B | ||
| Q2 24 | $3.9B | $5.4B |
| Q1 26 | $418.7M | — | ||
| Q4 25 | $-941.1M | $849.0M | ||
| Q3 25 | $341.3M | $859.0M | ||
| Q2 25 | $257.6M | $884.0M | ||
| Q1 25 | $287.7M | $654.0M | ||
| Q4 24 | $448.0M | $546.0M | ||
| Q3 24 | $385.9M | $834.0M | ||
| Q2 24 | $328.1M | $825.0M |
| Q1 26 | — | — | ||
| Q4 25 | -10.6% | 64.5% | ||
| Q3 25 | 18.7% | 63.6% | ||
| Q2 25 | 16.6% | 63.8% | ||
| Q1 25 | 17.1% | 63.8% | ||
| Q4 24 | 19.8% | 64.9% | ||
| Q3 24 | 19.6% | 64.0% | ||
| Q2 24 | 17.7% | 63.0% |
| Q1 26 | 10.4% | — | ||
| Q4 25 | -17.7% | 25.2% | ||
| Q3 25 | 13.1% | 18.7% | ||
| Q2 25 | 10.9% | 18.5% | ||
| Q1 25 | 12.3% | 14.3% | ||
| Q4 24 | 15.9% | 9.0% | ||
| Q3 24 | 15.5% | 19.7% | ||
| Q2 24 | 13.2% | 19.4% |
| Q1 26 | 6.7% | — | ||
| Q4 25 | -17.0% | 11.8% | ||
| Q3 25 | 8.5% | 14.2% | ||
| Q2 25 | 6.4% | 14.7% | ||
| Q1 25 | 7.8% | 11.1% | ||
| Q4 24 | 10.4% | 8.5% | ||
| Q3 24 | 9.9% | 15.2% | ||
| Q2 24 | 8.5% | 15.2% |
| Q1 26 | $1.35 | — | ||
| Q4 25 | $-4.78 | $2.20 | ||
| Q3 25 | $1.75 | $2.22 | ||
| Q2 25 | $1.31 | $2.29 | ||
| Q1 25 | $1.45 | $1.69 | ||
| Q4 24 | $2.27 | $1.41 | ||
| Q3 24 | $1.95 | $2.16 | ||
| Q2 24 | $1.65 | $2.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.0B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $22.4B |
| Total Assets | — | $47.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $4.0B | ||
| Q3 25 | — | $3.3B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $3.7B | ||
| Q3 24 | — | $3.9B | ||
| Q2 24 | — | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | $9.3B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $6.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $12.0B | $22.4B | ||
| Q3 25 | $4.6B | $21.8B | ||
| Q2 25 | $4.5B | $21.2B | ||
| Q1 25 | $4.4B | $20.9B | ||
| Q4 24 | $4.2B | $20.6B | ||
| Q3 24 | $4.0B | $20.1B | ||
| Q2 24 | $3.6B | $19.8B |
| Q1 26 | — | — | ||
| Q4 25 | $54.4B | $47.8B | ||
| Q3 25 | $28.8B | $47.1B | ||
| Q2 25 | $28.8B | $46.3B | ||
| Q1 25 | $28.1B | $46.0B | ||
| Q4 24 | $29.6B | $43.0B | ||
| Q3 24 | $28.8B | $43.8B | ||
| Q2 24 | $27.3B | $39.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.77× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.1B |
| Free Cash FlowOCF − Capex | — | $1.9B |
| FCF MarginFCF / Revenue | — | 26.1% |
| Capex IntensityCapex / Revenue | — | 3.7% |
| Cash ConversionOCF / Net Profit | — | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $2.1B | ||
| Q3 25 | $477.5M | $1.5B | ||
| Q2 25 | $210.1M | $1.1B | ||
| Q1 25 | $-786.8M | $250.0M | ||
| Q4 24 | $1.9B | $1.9B | ||
| Q3 24 | $568.7M | $1.5B | ||
| Q2 24 | $-141.7M | $633.0M |
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $1.9B | ||
| Q3 25 | $438.4M | $1.4B | ||
| Q2 25 | $168.0M | $928.0M | ||
| Q1 25 | $-816.3M | $127.0M | ||
| Q4 24 | $1.9B | $1.7B | ||
| Q3 24 | $537.4M | $1.3B | ||
| Q2 24 | $-180.9M | $481.0M |
| Q1 26 | — | — | ||
| Q4 25 | 54.2% | 26.1% | ||
| Q3 25 | 10.9% | 22.3% | ||
| Q2 25 | 4.2% | 15.4% | ||
| Q1 25 | -22.1% | 2.2% | ||
| Q4 24 | 43.5% | 25.9% | ||
| Q3 24 | 13.8% | 23.7% | ||
| Q2 24 | -4.7% | 8.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | 3.7% | ||
| Q3 25 | 1.0% | 3.1% | ||
| Q2 25 | 1.0% | 3.0% | ||
| Q1 25 | 0.8% | 2.1% | ||
| Q4 24 | 1.1% | 4.1% | ||
| Q3 24 | 0.8% | 3.1% | ||
| Q2 24 | 1.0% | 2.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.52× | ||
| Q3 25 | 1.40× | 1.79× | ||
| Q2 25 | 0.82× | 1.26× | ||
| Q1 25 | -2.73× | 0.38× | ||
| Q4 24 | 4.30× | 3.54× | ||
| Q3 24 | 1.47× | 1.77× | ||
| Q2 24 | -0.43× | 0.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OMC
Segment breakdown not available.
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
